Preview Health

Preview Health is a life sciences company focused on developing AI-powered diagnostics. The company was founded by Dr. Diana Zhang, who serves as CEO & CSO, and Anastasia Latin, a global health specialist. Dr. Zhang's background includes a PhD and a Fulbright Fellowship, during which she conducted research using machine learning and chemical methods for disease diagnosis. Her work demonstrated that an AI tool could detect Parkinson's disease with up to 96% accuracy, up to 15 years before a clinical diagnosis, which became the foundational technology for the company. Anastasia Latin's experience in MedTech service delivery, psychology, and public health, including a successful customer conversion program at Cochlear, motivated her to co-found Preview Health to address systemic healthcare barriers.

The company's core technology analyzes metabolites, the small molecules produced during the body's metabolic functions, from a biological sample. By using advanced chemistry to study thousands of these metabolites and applying its proprietary AI, Preview Health creates a "molecular fingerprint." This detailed biomarker profile provides a real-time view of an individual's health, enabling the early and precise detection of complex diseases. Their initial focus is a test for Parkinson's disease, which analyzes bloodwork to identify the condition years before clinical symptoms appear.

Preview Health operates in the precision medicine and diagnostics market. Its business model appears to target multiple client types. For pharmaceutical companies and research organizations, it aims to accelerate and optimize clinical trials by improving trial design and execution through molecular assessments of patient suitability, safety, and efficacy. For healthcare providers and patients, it offers a tool for early and precise diagnosis to enable prompt medical intervention. The company's technology has the potential to differentiate between diseases with similar early symptoms, such as Parkinson's, Multiple Systems Atrophy, or Dementia with Lewy Bodies.

Keywords: precision medicine, diagnostics, AI diagnostics, molecular fingerprinting, biomarker analysis, metabolomics, Parkinson's disease, early disease detection, clinical trial optimization, neurodegenerative disorders, Dr. Diana Zhang, Anastasia Latin, machine learning in healthcare, blood-based diagnostics, preventative healthcare, health technology, MedTech, life sciences, personalized medicine, biomarker discovery